Veeva SystemsMEX:VEEV +2.13%93 PS Ratio is 9.41 as of Jul. 08, 2026, which is 40% below its 10-year median of 15.65. GuruFocus rates MEX:VEEV with a GF Score™ of 93/100 and a GF Value™ of MXN5,006.28 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 658 Healthcare Providers & Services companies, Veeva Systems ranks worse than 91.19% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Veeva Systems's share price is MXN3360.00.
Veeva Systems's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was MXN356.88. Hence, Veeva Systems's PS Ratio for today is 9.41.
The historical rank and industry rank for Veeva Systems's PS Ratio or its related term are showing as below:
MEX:VEEV'
s PS Ratio Range Over the Past 10 Years
Min: 7.74 Med: 15.65 Max: 39.56
Current: 9.71
During the past 13 years, Veeva Systems's highest PS Ratio was 39.56. The lowest was 7.74. And the median was 15.65.
MEX:VEEV's PS Ratio is ranked worse than 91.19% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: 1.49
vs MEX:VEEV: 9.71
Veeva Systems Inc has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Veeva Systems was 14.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 13.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 15.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 21.40% per year.
During the past 13 years, Veeva Systems's highest 3-Year average Revenue per Share Growth Rate was 130.60% per year. The lowest was 6.50% per year. And the median was 25.10% per year.
Back to Basics: PS Ratio
Veeva Systems (MEX:VEEV) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Veeva Systems PS Ratio Related Terms
Veeva Systems PS Ratio Historical Data
* Premium members only.
The historical data trend for Veeva Systems's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Veeva Systems's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's PS Ratio distribution charts can be found below:
* The bar in red indicates where Veeva Systems's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Veeva Systems's Share Price of today is MXN3360.00. Veeva Systems's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN356.88.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Veeva Systems (MEX:VEEV) has a PS Ratio of 9.41 as of Jul. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Veeva Systems and its competitors. This is 40% below median its historical median of 15.65. Over the past decade, Veeva Systems' PS Ratio has ranged from 7.74 to 39.56. According to the industry distribution chart, Veeva Systems ranks #600 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 91.2%.
Is Veeva Systems' PS Ratio too high?
Veeva Systems' current PS Ratio of 9.41 is 40% below median its 10-year median of 15.65. Over the past 10 years, this metric has ranged from a low of 7.74 to a high of 39.56. The Healthcare Providers & Services industry median PS Ratio is 1.49. Veeva Systems' value of 9.41 is 531.5% above this industry median. Based on the distribution chart, Veeva Systems ranks #600 out of 658 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Veeva Systems has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' PS Ratio compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #600 out of 658 companies for PS Ratio. This places Veeva Systems in the lower half of its industry. The industry median PS Ratio is 1.49. Veeva Systems' value of 9.41 is 531.5% above this benchmark. Historically, Veeva Systems' own PS Ratio has ranged from 7.74 to 39.56 over the past decade. While the company's 10-year median is 15.65 vs. the industry median of 1.49, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.49, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current PS Ratio of 9.41 is 531.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current PS Ratio is 9.41, which is 40% below median its own 10-year median of 15.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (MEX:VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN5,006.28, compared to a current price of MXN3,360.00 — trading 32.9% below its estimated fair value. The current PS Ratio is 9.41, which is 40% below median its 10-year median of 15.65 and 531.5% above the Healthcare Providers & Services industry median of 1.49. Veeva Systems' overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Veeva Systems (MEX:VEEV), the current PS Ratio is 9.41 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (MEX:VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of MXN3,360.00 is trading 32.9% below its estimated GF Value™ of MXN5,006.28.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for MEX:VEEV:
PS Ratio: 9.41 (40% below median its 10-year median of 15.65)
GF Value™: MXN5,006.28 vs. price of MXN3,360.00 (32.9% below fair value)
Industry Position: 531.5% above the Healthcare Providers & Services median (#600 of 658)
No single metric tells the full story. See the MEX:VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
93GF Score
Get the complete analysis for MEX:VEEV
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:VEEV has been successfully added to your 
